General Information
Version
1.0
Revision date
2025-04-14
Product name
Ampicillin for Injection, USP
Substance name
Ampicillin for Injection, USP
CAS No.
69-52-3
1.2.1 Relevant identified uses
Penicillin Antibiotic
1.2.2. Uses advised against
No additional information available
Emergency telephone
+1-866-562-4708
Icons in SDS
Company Information
company name
WG Critical Care, LLC
e-mail address of the competent person responsible for the Safety Data Sheet
wgccquality@wgcriticalcare.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS-US Classification Respiratory sensitization, Category 1 Skin sensitization, Category 1 Combustible dust H334 H317
2.2 Label elements
GHS-US Labeling
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
May form combustible dust concentrations in air [if small particles are generated during further processing, handling or by other means]. H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing dust. P272 - Contaminated work clothing must not be allowed out of the workplace. P280 - Wear eye protection, protective gloves and clothing. P284 - In case of inadequate ventilation wear dust mask. P302+P352 - If on skin: Wash with plenty of soap and water. P304+P340 - If inhaled: Remove person to fresh air and keep at rest in a position comfortable for breathing. P321 - Specific treatment (see Section 4 of this Safety Data Sheet on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice or attention. P342+P311 - If experiencing respiratory symptoms: Call a poison center or doctor. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents and/or container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulations. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Proper grounding procedures to avoid static electricity should be followed. Prevent dust accumulation (to minimize explosion hazard). Avoid generating dust. 2.3 Hazards associated with known or reasonably anticipated uses This product is a pharmaceutical product designed for administration to a patient by a qualified medical professional. No other uses are anticipated. A Process Hazard Analysis (PHA) or other hazard assessment for additional specific end uses should be performed to ensure that hazards are fully understood, and adequate safety measures are in place. See Section 10 for relevant reactivity and stability information.
Other hazards
Exposure may aggravate pre-existing eye, skin, or respiratory conditions
Ingredient(s) with unknown acute toxicity
No data available
2.1 Classification of the substance or mixture
GHS-US Classification Respiratory sensitization, Category 1 H334 Skin sensitization, Category 1 H317 Combustible dust